NWBS Northw.Bio Regs

 

TIDMNWBS TIDMNWBT 
 
RNS Number : 7202U 
Northwest Biotherapeutics Inc 
30 June 2009 
 

For immediate release 
                    June 30, 2009 
 
 
 
 
 
 
Northwest Biotherapeutics 
("NWBT" or the "Company") 
 
 
Posting of Annual Report of Accounts and Update on Cash Position 
 
 
Northwest Biotherapeutics, Inc. (AIM: NWBS and NWBT; OTC BB: NWBO.US), 
announces that printed copies of its Annual Report and Accounts for the year 
ended 31 
December 2008 were distributed to shareholders on 29 June 2009. An electronic 
copy of this document is available from the Company's website, and is also 
available at the registered office of the Company. 
 
 
The Company will hold its annual meeting later this summer. 
 
 
The Company believes that it has sufficient cash at hand to fund operations into 
July 2009, however the Company will need to raise additional capital to fund its 
clinical trials and other operating activities and to repay indebtedness in due 
course. Shareholders should be aware that if the Company's capital raising 
efforts are unsuccessful, this will have a material adverse effect on the 
Company's financial position and operations. 
 
 
 
 
 
 
For further information, please contact: 
 
 
Northwest Biotherapeutics 
Alton Boynton, President and Chief Executive Officer 
+1 240-497-9024 
 
 
Buchanan Communications 
Lisa Baderoon (lisab@buchanan.uk.com) / Mary-Jane Johnson / 
Catherine Breen 
+44 (0)20 7466 5000 
 
 
Collins Stewart 
Adam Cowen/Adrian Hadden +44 (0)20 7523 8000 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 MSCPUUWGQUPBGQB 
 

Northw.Bio Regs (LSE:NWBS)
Historical Stock Chart
From May 2024 to Jun 2024

Northw.Bio Regs (LSE:NWBS)
Historical Stock Chart
From Jun 2023 to Jun 2024